Russia's Sputnik V vaccine has demonstrated 97.2% efficacy against COVID-19 during the vaccination campaign in Belarus, Russia's RDIF sovereign wealth fund said on Wednesday.
The Russian Direct Investment Fund is marketing the two-shot vaccine abroad.
REUTERS / Reporting by Maria Kiselyova; writing by Tom Balmforth; editing by Gabrielle Tรฉtrault-Farber
By A Robin - September 16, 2021

_03-27-2026_08-27.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)



.jpg)


Leave a comment